Cytokeratin expression and distribution in adamantinoma of the long bones and osteofibrous dysplasia of tibia and fibula. An immunohistochemical study correlated to histogenesis.
Twenty-four cases of adamantinoma and 24 cases of osteofibrous dysplasia of the long bones were studied to evaluate the expression and distribution of cytokeratin (CK) subtypes in relation to histogenesis and differentiation. The immunohistochemical study was performed on tissue fixed in buffered formalin and embedded in paraffin wax utilizing antibodies to vimentin, factor VIII, epithelial membrane antigen and cytokeratins of different molecular weights. In all cases the vimentin antibody marked positively in stroma, endothelium and osteoblasts, while factor VIII expression was confined to endothelial cells. In 71% of adamantinomas, vimentin showed strong immunoreactivity in the tumour cells of nests and tubules. CKAE1/AE3 and CK19 were strongly expressed in all morphological patterns of adamantinoma emphasizing their epithelial origin, while the antibodies to CK8 and CK18 showed a high percentage of negative responses. In osteofibrous dysplasia the epithelial-like component was much smaller than in adamantinoma and was present in scattered islands composed of a few cell positive for CKAE1/AE3 and CK19 and negative for other keratins. These results suggest that these two lesions are of a similar histogenesis.
Benassi
M S
MS
Oncology Research Laboratory, Istituto di Ricerca Codivilla-Putti I.O.R., Bologna, Italy.
Campanacci
L
L
Gamberi
G
G
Ferrari
C
C
Picci
P
P
Sangiorgi
L
L
Campanacci
M
M
D000564:Ameloblastoma / Q000378:metabolism* / Q000473:pathology; D000911:Antibodies, Monoclonal; D001859:Bone Neoplasms / Q000378:metabolism* / Q000473:pathology; D005260:Female; D005357:Fibrous Dysplasia of Bone / Q000378:metabolism* / Q000473:pathology; D005360:Fibula / Q000378:metabolism / Q000473:pathology*; D006801:Humans; D007150:Immunohistochemistry; D007633:Keratins / Q000032:analysis*; D008297:Male; D013977:Tibia / Q000378:metabolism / Q000473:pathology*; D014746:Vimentin / Q000032:analysis
D000911:Antibodies, Monoclonal; D014746:Vimentin; D007633:Keratins